Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.
about
Hyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?EGFR-TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non-Small Cell Lung Cancer.
P2860
Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic Dilemmas.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Tyrosine Kinase Inhibitor-Indu ...... ges, and Therapeutic Dilemmas.
@en
type
label
Tyrosine Kinase Inhibitor-Indu ...... ges, and Therapeutic Dilemmas.
@en
prefLabel
Tyrosine Kinase Inhibitor-Indu ...... ges, and Therapeutic Dilemmas.
@en
P2860
P1433
P1476
Tyrosine Kinase Inhibitor-Indu ...... ges, and Therapeutic Dilemmas.
@en
P2093
Rashmi R Shah
P2860
P2888
P304
P356
10.1007/S40264-016-0450-9
P577
2016-08-17T00:00:00Z
P6179
1013085969